mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
VX-680 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
0.0001 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.2 |
0.0001 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
GW843682X |
GDSC1000 |
pan-cancer |
AAC |
0.19 |
0.0002 |
mRNA |
BRD-K28456706 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |